These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9120402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.
    Kitching AR, Turner AL, O'Sullivan KM, Dewerchin M, Lijnen HR.
    J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042
    [Abstract] [Full Text] [Related]

  • 4. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5899-904. PubMed ID: 8650190
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.
    Kitching AR, Kong YZ, Huang XR, Davenport P, Edgtton KL, Carmeliet P, Holdsworth SR, Tipping PG.
    J Am Soc Nephrol; 2003 Jun 11; 14(6):1487-95. PubMed ID: 12761249
    [Abstract] [Full Text] [Related]

  • 6. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.
    Hertig A, Berrou J, Allory Y, Breton L, Commo F, Costa De Beauregard MA, Carmeliet P, Rondeau E.
    FASEB J; 2003 Oct 11; 17(13):1904-6. PubMed ID: 12897066
    [Abstract] [Full Text] [Related]

  • 7. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
    Hijazi N, Abu Fanne R, Abramovitch R, Yarovoi S, Higazi M, Abdeen S, Basheer M, Maraga E, Cines DB, Higazi AA.
    Blood; 2015 Apr 16; 125(16):2558-67. PubMed ID: 25673638
    [Abstract] [Full Text] [Related]

  • 8. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H, Vaheri A.
    Cell Mol Life Sci; 2004 Nov 16; 61(22):2840-58. PubMed ID: 15558213
    [Abstract] [Full Text] [Related]

  • 9. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V, Medved L, Lijnen HR, Ingham K.
    J Biol Chem; 1995 Apr 14; 270(15):8680-5. PubMed ID: 7721771
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activators direct reorganization of the liver lobule after acute injury.
    Bezerra JA, Currier AR, Melin-Aldana H, Sabla G, Bugge TH, Kombrinck KW, Degen JL.
    Am J Pathol; 2001 Mar 14; 158(3):921-9. PubMed ID: 11238040
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J.
    EMBO J; 2006 Jun 21; 25(12):2686-97. PubMed ID: 16763560
    [Abstract] [Full Text] [Related]

  • 12. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM.
    J Clin Invest; 1998 Sep 01; 102(5):919-28. PubMed ID: 9727060
    [Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
    Akassoglou K, Kombrinck KW, Degen JL, Strickland S.
    J Cell Biol; 2000 May 29; 149(5):1157-66. PubMed ID: 10831618
    [Abstract] [Full Text] [Related]

  • 14. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H, Zhang Y, Heuckeroth RO.
    Hepatology; 2007 Jun 29; 45(6):1527-37. PubMed ID: 17538930
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH, Holdsworth SR, Tipping PG.
    Am J Pathol; 1997 Mar 29; 150(3):873-80. PubMed ID: 9060825
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis.
    Aya N, Yoshioka K, Murakami K, Hino S, Okada K, Matsuo O, Maki S.
    J Pathol; 1992 Mar 29; 166(3):289-95. PubMed ID: 1381427
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of urokinase-type and tissue-type plasminogen activators in a rabbit model of renal ischemia/reperfusion.
    Sugiki M, Omura S, Yoshida E, Itoh H, Kataoka H, Maruyama M.
    J Biochem; 2002 Sep 29; 132(3):501-8. PubMed ID: 12204121
    [Abstract] [Full Text] [Related]

  • 20. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
    Cooper JM, Rastogi A, Krizo JA, Mintz EM, Prosser RA.
    Eur J Neurosci; 2017 Mar 29; 45(6):805-815. PubMed ID: 27992087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.